Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pyrrole tricyclic compounds as A2A / A2B inhibitors

Pyrrole tricyclic compounds as A2A / A2B inhibitors

US Patent 11220510 · Granted Jan 11, 2022

Estimated economic value: $54,624,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Naphthyridine compounds as inhibitors of KRAS2025
Pyrrolotriazine compounds as tam inhibitors2025
Pyrrolotriazine compounds as tam inhibitors2025
Pyrrolotriazine compounds as tam inhibitors2025
Quinoline compounds as inhibitors of KRAS2025
Quinoline compounds as inhibitors of KRAS2025
Hetero-bicyclic inhibitors of KRAS2025
Heterocyclylamines as PI3K inhibitors2025
Tricyclic urea compounds as JAK2 V617F inhibitors2024
Imidazotriazines and imidazopyrimidines as kinase inhibitors2024
Imidazole and triazole KRAS inhibitors2024
CD73 inhibitor and A2A/A2B adenosine receptor inhibitor combination therapy2024